Edge
StocktwitsEarnings

Official STOCKTWITS Representative

$BSX Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of $0.62 up 14.81% YoY
• Reported revenue of $5.44B up 7.53% YoY
• Boston Scientific estimates third quarter 2026 net sales growth of 3 to 5 percent and adjusted EPS of $0.80 to $0.82, with full year 2026 adjusted EPS of $3.28 to $3.32.Price since post
Advertisement|Remove ads.